YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Wockhardt
Wockhardt
BSE: 532300NSE: WOCKPHARMAISIN: INE049B01025

8th-Apr-2021 21:37Source: BSE

Wockhardt - Statement Of Investor Complaints For The Quarter Ended March 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- Gajanand Sahu
Designation :- Company Secretary and Compliance Officer

Sections